Loading…
Loading…
CYIO does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CYIO and 80,000+ other tickers.
See exactly how CYIO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CYIO and 80,000+ other tickers.
CYIOS Corporation, operating through its various subsidiaries, is dedicated to establishing a comprehensive cryptocurrency ecosystem. This integrated platform offers crypto lending services via the Helio's CeFi Aggregator, supports digital currency trading through the Helio Exchange, and facilitates the creation and exchange of NFTs on the Randombly NFT Marketplace. Beyond its digital asset focus, the company also manages Choice Wellness, a division focused on developing and marketing proprietary health and wellness products, such as the DR's CHOICE and 24 brands. Additionally, CYIOS is…
MELBOURNE, Australia and PALM BEACH, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- CYIOS Corporation LLC (OTC: CYIO) (“CYIOS” or the “Company”), a Nevada-registered holding company focused on acquisitions, modernization and technology integration in the healthcare and medical supply sectors, today announced it has engaged Atlanta Capital Partners, LLC to lead a renewed investor relations strategy designed to expand CYIOS's visibility and enhance communication across the investment community.
MELBOURNE, Australia and PALM BEACH, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CYIOS Corporation (OTC: CYIO) today announced that David Lewis has stepped down from his roles with CYIOS, and as part of this transition, he has voluntarily agreed to return 16,560 Series D Preferred Shares to the Company, and cancel all outstanding salary and loan obligations. This decisive step strengthens the company's balance sheet, simplifies its capital structure, and positions CYIOS for its next stage of growth. We wish David all the best for his next endeavor.
2024 marks a transformative year for CYIOS Corp, with Noir achieving over 200% year-over-year growth; strategic plans set for continued expansion in 2025. BOCA RATON, FL / ACCESS Newswire / January 16, 2025 / CYIOS Corp (OTC PINK:CYIO) is pleased to announce that its wholly-owned subsidiary, Noir Medical Supplies, delivered a record-breaking $5 million in revenue during Q4 2024.
Noir Expects to See Strong Revenue Growth in 2024 Exceeding $7M, Up from $4.6M in 2023 BOCA RATON, FL / ACCESSWIRE / September 11, 2024 / CYIOS Corp (OTC PINK:CYIO), a publicly traded holding company, is pleased to announce it has successfully closed the strategic acquisition of Noir Medical Supplies, ("Noir") a company specializing in providing top-tier medical equipment and supplies. The acquisition marks a significant milestone for CYIOS with anticipated strong revenue growth in 2024 exceeding $7Million, up from $4.6Million in 2023.
BOCA RATON, FL / ACCESSWIRE / February 27, 2024 / CYIOS Corp (OTC PINK:CYIO), a publicly traded holding company is pleased to provide the following shareholder update. Today, the company is very pleased to announce the release of its completely revamped and updated carbon offset platform, CarbonCred, a subscription based carbon offset marketplace that empowers businesses and individuals to quickly and easily offset their carbon footprint by supporting carbon neutrality projects in the US and around the world.